UK fertilisation authority launches consultation on mitochondrial replacement techniques

BMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e6259 (Published 18 September 2012)
Cite this as: BMJ 2012;345:e6259

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Toby Pitts-Tucker
  1. 1BMJ

The UK Human Fertilisation and Embryology Authority (HFEA) has launched a public consultation on the ethical and social implications of new in vitro fertilisation (IVF) techniques designed to avoid the maternal transmission of mitochondrial disease.

Mitochondrial disease affects around one in 200 births each year in the United Kingdom, the HFEA says, and can affect a number of different organs with varying severity.

Two new techniques, maternal spindle transfer and pro-nuclear transfer, could enable women to avoid passing these diseases on to their offspring. Both use a donor’s mitochondria to create a healthy embryo that would then be used in normal IVF treatment. Offspring would thereby share DNA with three people and have an altered germ line such …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL